Article Information
History
- December 19, 2020.
Article Versions
- Version 1 (December 4, 2020 - 14:48).
- Version 2 (December 5, 2020 - 18:36).
- You are viewing Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Atsushi Miyawaki, MD, PhD1,
- Takahiro Tabuchi, MD, PhD2,
- Yasutake Tomata, PhD3 and
- Yusuke Tsugawa, MD, PhD4,5,*
- 1Department of Public Health, Graduate School of Medicine, the University of Tokyo, Bunkyo-Ku, Tokyo, Japan
- 2Cancer Control Center, Osaka International Cancer Institute, Osaka, Osaka, Japan
- 3Faculty of Health and Social Services, Kanagawa University of Human Services, Yokosuka, Kanagawa, Japan
- 4Division of General Internal Medicine and Health Services Research, UCLA David Geffen School of Medicine, Los Angeles, CA
- 5Department of Health Policy and Management, UCLA Fielding School of Public Health, Los Angeles, CA
- ↵*Corresponding Author:
Yusuke Tsugawa, MD, PhD, Assistant Professor of Medicine & Health Policy and Management, UCLA David Geffen School of Medicine, Email: ytsugawa{at}mednet.ucla.edu, Tel: 310-794-2523
Posted December 19, 2020.
Association between Participation in Government Subsidy Program for Domestic Travel and Symptoms Indicative of COVID-19 Infection
